Pediatric SLE-towards a comprehensive management plan

被引:51
作者
Brunner, Hermine I. [1 ,2 ]
Huggins, Jennifer [1 ,2 ]
Klein-Gitelman, Marisa S. [3 ]
机构
[1] Univ Cincinnati, Coll Med, Cincinnati Childrens Hosp Med Ctr, Div Rheumatol, Cincinnati, OH 45229 USA
[2] Univ Cincinnati, Coll Med, Cincinnati Childrens Hosp Med Ctr, Lupus Ctr, Cincinnati, OH 45229 USA
[3] Northwestern Univ, Feinberg Sch Med, Childrens Mem Hosp, Div Pediat Rheumatol, Chicago, IL 60614 USA
关键词
SYSTEMIC-LUPUS-ERYTHEMATOSUS; QUALITY-OF-LIFE; CHILDHOOD-ONSET; MYCOPHENOLATE-MOFETIL; DISEASE-ACTIVITY; CORTICOSTEROID-THERAPY; INDUCTION TREATMENT; FOLLOW-UP; B-CELLS; NEPHRITIS;
D O I
10.1038/nrrheum.2011.15
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Systemic lupus erythematosus (SLE) results from complex abnormalities of the innate and acquired immune systems. For reasons that are currently not well understood, the disease course and phenotype associated with SLE, although quite variable, are generally more severe when the diagnosis is made during childhood. Active disease, infections, lupus nephritis, and neuropsychiatric SLE manifestations are associated with higher morbidity and mortality. Unlike in adult-onset SLE, systemic glucocorticoid therapy and immunosuppressive medications are needed for the treatment of the majority of children and adolescents with SLE. The complex nature of childhood-onset SLE demands a comprehensive, multidisciplinary management approach that considers the patients' growth and development, their educational needs, and the unpredictable course of SLE and its complications.
引用
收藏
页码:225 / 233
页数:9
相关论文
共 70 条
[11]  
2-4
[12]  
Calano SJ, 2006, ADV EXP MED BIOL, V586, P381
[13]  
Cervera R, 2002, ANN MED INTERNE, V153, P530
[14]   A modular analysis framework for blood genomics studies: Application to systemic lupus erythematosus [J].
Chaussabel, Damien ;
Quinn, Charles ;
Shen, Jing ;
Patel, Pinakeen ;
Glaser, Casey ;
Baldwin, Nicole ;
Stichweh, Dorothee ;
Blankenship, Derek ;
Li, Lei ;
Munagala, Indira ;
Bennett, Lynda ;
Allantaz, Florence ;
Mejias, Asuncion ;
Ardura, Monica ;
Kaizer, Ellen ;
Monnet, Laurence ;
Allman, Windy ;
Randall, Henry ;
Johnson, Diane ;
Lanier, Aimee ;
Punaro, Marilynn ;
Wittkowski, Knut M. ;
White, Perrin ;
Fay, Joseph ;
Klintmalm, Goran ;
Ramilo, Octavio ;
Palucka, A. Karolina ;
Banchereau, Jacques ;
Pascual, Virginia .
IMMUNITY, 2008, 29 (01) :150-164
[15]  
COOK CD, 1960, PEDIATRICS, V26, P570
[16]   Low blood concentration of hydroxychloroquine is a marker for and predictor of disease exacerbations in patients with systemic lupus erythematosus [J].
Costedoat-Chalumeau, Nathalie ;
Amoura, Zahir ;
Hulot, Jean-Sebastien ;
Abou Hammoud, Hala ;
Aymard, Guy ;
Cacoub, Patrice ;
Frances, Camille ;
Wechsler, Bertrand ;
Huong, Du Le Thi ;
Ghillani, Pascale ;
Musset, Lucile ;
Lechat, Philippe ;
Piette, Jean-Charles .
ARTHRITIS AND RHEUMATISM, 2006, 54 (10) :3284-3290
[17]   Psychological correlates of adherence to self-care, disease activity and functioning in persons with systemic lupus erythematosus [J].
Duvdevany, I. ;
Cohen, M. ;
Minsker-Valtzer, A. ;
Lorber, M. .
LUPUS, 2011, 20 (01) :14-22
[18]  
FERRAZ MB, 1994, CLIN EXP RHEUMATOL, V12, P83
[19]   SYSTEMIC LUPUS-ERYTHEMATOSUS IN CHILDHOOD - CLINICAL MANIFESTATIONS AND IMPROVED SURVIVAL IN 55 PATIENTS [J].
GLIDDEN, RS ;
MANTZOURANIS, EC ;
BOREL, Y .
CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY, 1983, 29 (02) :196-210
[20]   Changes in the survival of patients with systemic lupus erythematosus in childhood:: 30 years experience in Chile [J].
González, B ;
Hernández, P ;
Olguín, H ;
Miranda, M ;
Lira, L ;
Toso, M ;
Quezada, A ;
Norambuena, X ;
Talesnik, E ;
Méndez, C ;
Navarrete, C .
LUPUS, 2005, 14 (11) :918-923